MedPath

anisum effect on migrane headache

Not Applicable
Conditions
migrane headache.
Migraine
Registration Number
IRCT20140108016143N2
Lead Sponsor
Shiraz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
50
Inclusion Criteria

age between 18-65
Migraine
Having at least two migraine attacks per month over the past three months

Exclusion Criteria

pregnancy,
lactation
any other neurological disorder
known allergy to anise and/or related products

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Frequency of headache. Timepoint: week 0,3,6. Method of measurement: The patient records daily headaches.;Quality of life. Timepoint: week 0 , 3 ,6. Method of measurement: headache impact test-6 (HIT-6) questionnaire.;Total analgesic consumption. Timepoint: week 0,3,6. Method of measurement: The number of the medication in each interval is recorded on a daily basis by the patient.;Headache duration. Timepoint: week 0 , 3 ,6. Method of measurement: The patient records daily headaches duration.;Headache severity. Timepoint: week 0 , 3 ,6. Method of measurement: The patient records daily headaches severity from 0 to 10.
Secondary Outcome Measures
NameTimeMethod
Any observed adverse event. Timepoint: Sixth week after intervention. Method of measurement: self reporting of patients.
© Copyright 2025. All Rights Reserved by MedPath